Status:
COMPLETED
The PRognostic Effect of Environmental Factors in Crohn's and Colitis
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
University of Aberdeen
Wellcome Sanger Institute
Conditions:
Inflammatory Bowel Diseases
Crohn Disease
Eligibility:
All Genders
6+ years
Brief Summary
The PREdiCCt Study: This is a major study that is now being launched. This is the first study of its kind and is specifically directed toward understanding how environmental factors and the gut micro...
Detailed Description
Background Inflammatory bowel disease (IBD) is a common cause of chronic ill-health among young people in the UK (prevalence estimated at 1 in 200 for adults and 1 in 2000 for children, with a peak i...
Eligibility Criteria
Inclusion
- \- Confirmed Crohn's disease or ulcerative colitis or IBDU (Lennard-Jones/Porto criteria).
- Clinical remission (see definition Section 3.2 of protocol) \>6 months since diagnosis with Crohn's disease, ulcerative colitis or IBDU \>2 months since any change in therapy for Crohn's disease, ulcerative colitis or IBDU Aged six years or over at study entry Written informed consent obtained from patient or parent / guardian
Exclusion
- \- Patient unwilling to take part in all aspects of the study Unable to obtain written informed consent Systemic corticosteroids (oral or intravenous) within the last two months Thiopurines / methotrexate / biologic therapy started in the preceding two months
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 20 2022
Estimated Enrollment :
2629 Patients enrolled
Trial Details
Trial ID
NCT03282903
Start Date
November 1 2016
End Date
March 20 2022
Last Update
May 20 2024
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
Aberdeen Royal Infirmary
Aberdeen, United Kingdom
2
Bronglais General Hospital
Aberystwyth, United Kingdom
3
NHS Lanarkshire
Airdrie, United Kingdom
4
Ulster Hospital
Belfast, United Kingdom, BT16 1RH